Xolair
® (
omalizumab) is a medication approved for preventing
asthma attacks caused by allergic
asthma. It should only be used in people whose asthma is not adequately controlled by inhaled steroids.
The medicine is available by prescription only and comes in injectable form. Xolair injections are typically given every two to four weeks by your healthcare provider. By binding to IgE antibodies (which play an important role in allergic reactions), the medication can block the effects of allergic reactions and help prevent asthma attacks.
You should talk to your healthcare provider before getting Xolair injections if you have never had
chickenpox or the
measles, are pregnant or thinking of becoming pregnant, or have eczema.
(Click Xolair for more information on how Xolair works, to learn about the specific effects of this medicine, and to find out what side effects may occur.)
